Effective plaque removal with a new 8 French‐compatible atherectomy catheter

The purpose of this study was to evaluate the safety and efficacy of the new 8 Fr guide catheter‐compatible Flexicut directional atherectomy device and to compare it with the conventional Atherocath GTO catheter. The 6 Fr Flexicut catheter has a larger cutting window and a titanium nitride‐coated cutter to effect more tissue removal as well as treat mildly calcified lesions. A group of 143 lesions in 117 consecutive patients treated with the Flexicut catheter in four centers were compared with a control group of 277 lesions in 212 consecutive patients treated with the GTO device. Postatherectomy luminal diameters were larger (2.92 ± 0.79 vs. 2.52 ± 0.64 mm; P < 0.0001), with more luminal gain (relative gain: 0.58 ± 0.24 vs. 0.48 ± 0.25; P = 0.0007) using fewer directional coronary atherectomy (DCA) cuts (12 ± 7 vs. 16 ± 9; P = 0.0001) in the Flexicut group. A residual diameter stenosis < 20% immediately after DCA was obtained in 77% of the lesions in the Flexicut group vs. 45% in the GTO group (P < 0.0001). Histology in the former group revealed large calcium speckles in the retrieved specimens. In the Flexicut group, there was a lower incidence of access site complications and damage to the coronary ostium (2.5% vs. 7.5%; P = 0.08). The new Flexicut catheter is more effective than the conventional GTO catheter with a trend for reduced guiding catheter‐related complications. Cathet Cardiovasc Intervent 2002;56:452–459. © 2002 Wiley‐Liss, Inc.

[1]  C. Di Mario,et al.  Directional atherectomy prior to stenting in bifurcation lesions: A matched comparison study with stenting alone , 2001, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[2]  H. Uehata,et al.  Initial and long-term results of directional coronary atherectomy in unprotected left main coronary artery. , 2001, The American journal of cardiology.

[3]  T. Arakawa,et al.  Arterial remodeling influences the development of intimal hyperplasia after stent implantation. , 2001, Journal of the American College of Cardiology.

[4]  M. Leon,et al.  Effect of preintervention plaque burden on subsequent intimal hyperplasia in stented coronary artery lesions. , 2000, The American journal of cardiology.

[5]  K. Kuck,et al.  A synergistic approach to optimal stenting: directional coronary atherectomy prior to coronary artery stent implantation--the AtheroLink Registry. AtheroLink Study Group. , 2000, Journal of the American College of Cardiology.

[6]  T. Muramatsu,et al.  Efficacy of directional coronary atherectomy before stent implantation for coronary ostial lesions. , 2000, The Journal of invasive cardiology.

[7]  A. Colombo,et al.  Biodegradable stents : "fulfilling the mission and stepping away". , 2000, Circulation.

[8]  J. Tobis,et al.  Bifurcation lesions: two stents versus one stent--immediate and follow-up results. , 2000, Journal of the American College of Cardiology.

[9]  P. Fitzgerald,et al.  Effects of adjunctive balloon angioplasty after intravascular ultrasound-guided optimal directional coronary atherectomy: the result of Adjunctive Balloon Angioplasty After Coronary Atherectomy Study (ABACAS). , 1999, Journal of the American College of Cardiology.

[10]  F. Prati,et al.  In-stent neointimal proliferation correlates with the amount of residual plaque burden outside the stent: an intravascular ultrasound study. , 1999, Circulation.

[11]  I. Moussa,et al.  Plaque removal prior to stent implantation in native coronary arteries: why? when? and how? , 1998, The Journal of invasive cardiology.

[12]  I. Palacios,et al.  Directional coronary atherectomy for the treatment of Palmaz-Schatz in-stent restenosis. , 1998, The American journal of cardiology.

[13]  H. Dauerman,et al.  Mechanical debulking versus balloon angioplasty for the treatment of true bifurcation lesions. , 1998, Journal of the American College of Cardiology.

[14]  L. Angoli,et al.  Adjunctive stent implantation following directional coronary atherectomy in patients with coronary artery disease. , 1998, Journal of the American College of Cardiology.

[15]  C Di Mario,et al.  Stenting after optimal lesion debulking (sold) registry. Angiographic and clinical outcome. , 1998, Circulation.

[16]  M. Rozek,et al.  Acute directional coronary atherectomy prior to stenting in complex coronary lesions: ADAPTS Study. , 1998, Catheterization and cardiovascular diagnosis.

[17]  P. Fitzgerald,et al.  'Optimal' directional coronary atherectomy: final results of the Optimal Atherectomy Restenosis Study (OARS). , 1998, Circulation.

[18]  Samin K. Sharma,et al.  Final results of the Balloon vs Optimal Atherectomy Trial (BOAT) , 1998, Circulation.

[19]  R. Califf,et al.  Effect of platelet glycoprotein IIb/IIIa integrin blockade on activated clotting time during percutaneous transluminal coronary angioplasty or directional atherectomy (the EPIC trial) , 1995 .

[20]  M. Leon,et al.  Multivariate predictors of intravascular ultrasound end points after directional coronary atherectomy. , 1995, Journal of the American College of Cardiology.

[21]  P. Serruys,et al.  Directional atherectomy for treatment of restenosis within coronary stents: clinical, angiographic and histologic results. , 1992, Journal of the American College of Cardiology.